Venture Global, Inc.
VG NYSE Natural Gas Distribution Financials FY2023βFY2025
What Venture Global, Inc. does
No business description yet.
- Legal name
- Venture Global, Inc.
- Fiscal year ends
- December 31, 2025
- Latest annual report
- 10-K Β· Mar 2, 2026
- Accession Β· CIK
- 0002007855-26-000013
0002007855
Revenue and margins
Venture Global, Inc. had $13.8B of revenue in fiscal 2025, up 176.9% on the year before.
Net income and earnings per share
From fiscal 2023 to 2025, diluted EPS grew β17.1% a year. Loss periods are shown in red.
Returns on capital
After-tax operating income as a share of the money invested in the business: debt plus equity, minus cash.
Cash flow
Free cash flow was β$6.8B in fiscal 2025, β49.4% of revenue. Cash from operations minus capital spending.
Dividends, buybacks and share count
Venture Global, Inc. returned $465M to shareholders in fiscal 2025. The diluted share count rose 1.9%.
Balance sheet
Cash, debt and the ratios that show how comfortably Venture Global, Inc. can carry it.
| Fiscal year end | FY23 | FY24 | FY25 |
|---|---|---|---|
| Cash and short-term investments | $5.9B | $3.6B | $2.4B |
| Debt incl. finance leases | β | $29.3B | $34.5B |
| Net debt / EBITDA | β | 12.3x | 5.3x |
| Debt / equity | β | 10.1x | 5.1x |
| Interest coverage | 7.6x | 3.0x | 3.5x |
| Current ratio | β | 1.3x | 0.9x |
| Quick ratio | β | 1.2x | 0.9x |
| Total assets | β | $43.5B | $53.4B |
| Total liabilities | β | $35.6B | $41.5B |
| Shareholders' equity | β | $2.9B | $6.7B |
| Net debt (β = net cash) | β | $25.7B | $32.1B |
Insider trades
Open-market purchases and sales by officers, directors and 10% owners, from Form 4 filings. 'Plan' marks trades under a pre-arranged Rule 10b5-1 plan.
Bought, 12 months
$0.0M
0 insiders
Sold, 12 months
$0.0M
0 insiders
Of sales under plans
β
$0.0M
No open-market insider trades in the last 12 months.
Piotroski F-score
Nine pass/fail tests of profitability, funding and efficiency. 8β9 is strong, 0β2 weak.
| Test | FY23 | FY24 | FY25 |
|---|---|---|---|
| Net income is positive | β | β | β |
| Cash from operations is positive | β | β | β |
| Return on assets rose | β | β | β |
| Cash from operations exceeds net income | β | β | β |
| Debt fell relative to assets | β | β | β |
| Current ratio rose | β | β | β |
| Share count didn't rise | β | β | β |
| Gross margin rose | β | β | β |
| Revenue rose relative to assets | β | β | β |
| F-score | β / 3 | β / 4 | 6 / 8 |
| Accruals ratio | β | β0.9% | β7.9% |
| Altman Z'' | β | 0.71 | 1.07 |
3 years of figures
US$ millions unless stated. Hover a ratio's name for its definition.
| Fiscal year | FY23 | FY24 | FY25 |
|---|---|---|---|
| Income statement | |||
| Revenue | $7.9B | $5.0B | $13.8B |
| Research and development | $490M | $635M | $344M |
| Operating income | $4.9B | $1.8B | $5.2B |
| Interest expense | $641M | $584M | $1.5B |
| Pretax income | $4.4B | $2.2B | $3.4B |
| Income tax | $816M | $437M | $630M |
| Net income | $3.6B | $1.7B | $2.7B |
| Net income to common | $2.7B | $1.5B | $2.3B |
| Diluted EPS | $1.25 | $0.57 | $0.86 |
| Diluted shares | 2.14B | 2.59B | 2.64B |
| Cash flow | |||
| Cash from operations | $4.6B | $2.1B | $6.6B |
| Capital expenditure | $8.1B | $13.7B | $13.4B |
| Free cash flow | β$3.5B | β$11.6B | β$6.8B |
| Depreciation and amortization | $277M | $322M | $941M |
| Stock-based compensation | $28.0M | $22.0M | $46.0M |
| Dividends paid | $164M | $139M | $465M |
| Dividends and buybacks | $164M | $139M | $465M |
| Balance sheet | |||
| Cash and short-term investments | $5.9B | $3.6B | $2.4B |
| Total debt | β | $29.3B | $34.2B |
| Finance lease liabilities | β | β | $258M |
| Current assets | β | $4.6B | $4.0B |
| Current liabilities | β | $3.5B | $4.3B |
| Inventory | β | $171M | $253M |
| Total assets | β | $43.5B | $53.4B |
| Total liabilities | β | $35.6B | $41.5B |
| Shareholders' equity | β | $2.9B | $6.7B |
| Margins | |||
| Operating margin | 61.4% | 35.5% | 37.4% |
| EBITDA margin | 64.9% | 41.9% | 44.3% |
| Net margin | 45.8% | 35.1% | 19.8% |
| FCF margin | β44.8% | β232.7% | β49.4% |
| Returns | |||
| Return on capital | β | 4.9% | 10.9% |
| Return on capital employed | β | 4.4% | 10.5% |
| Return on equity | β | 60.3% | 56.7% |
| Return on assets | β | 4.0% | 5.6% |
| Return on tangible equity | β | 50.9% | 33.5% |
| Growth | |||
| Revenue growth | β | β37.0% | 176.9% |
| Net income growth | β | β51.7% | 56.5% |
| EPS growth | β | β54.4% | 50.9% |
| Share count change | β | 20.6% | 1.9% |
| Financial health | |||
| Net debt / EBITDA | β | 12.3x | 5.3x |
| Debt / equity | β | 10.1x | 5.1x |
| Interest coverage | 7.6x | 3.0x | 3.5x |
| Current ratio | β | 1.3x | 0.9x |
| Quick ratio | β | 1.2x | 0.9x |
| Capital allocation | |||
| Capex / revenue | 102.5% | 275.9% | 97.1% |
| Stock comp / revenue | 0.4% | 0.4% | 0.3% |
| Quality scores | |||
| Piotroski F-score | β | β | 6.0 |
| Altman Z'' | β | 0.7 | 1.1 |
| Accruals ratio | β | β0.9% | β7.9% |
Source: SEC EDGAR XBRL filings (CIK 0002007855). Data updated October 24, 2026. Quarterly fourth quarters are the full year minus the first nine months. For information only β not investment advice. Check the original filings before relying on any figure.